| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $966K | -81.9% | -90.8% |
| R&D Expense | $47.8M | -14.0% | +61.6% |
| SG&A Expense | $14.5M | +22.2% | +11.7% |
| Operating Income | -$62.0M | +0.3% | -89.4% |
| Pre-tax Income | -$59.7M | -0.7% | -103.4% |
| Income Tax | $0 | -100.0% | — |
| Net Income | -$59.7M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $74.6M | +4.8% | -6.6% |
| Short-term Investments | $129.4M | -29.9% | -25.6% |
| Accounts Receivable | $1.0M | +67.2% | +176.5% |
| Inventory | $2.1M | -21.2% | -24.8% |
| Current Assets | $216.1M | -18.5% | -19.5% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$175.1M | — | — |
| Capital Expenditures | $2.3M | — | — |
| Investing Cash Flow | $143.2M | — | — |
| Financing Cash Flow | $6.7M | — | — |
| Free Cash Flow | -$177.4M | — | — |
| -103.4% |
| EPS (Basic) | -$0.85 | +0.0% | -57.4% |
| EPS (Diluted) | -$0.85 | +0.0% | -57.4% |
| $251.7M |
| -16.4% |
| -16.4% |
| Current Liabilities | $30.1M | -9.3% | -38.3% |
| Total Liabilities | $51.5M | -6.6% | -37.3% |
| Stockholders' Equity | $200.2M | -18.6% | -8.5% |